Cadence Capital Management’s Merck MRK Stock Holding History

Cadence Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$2.8M	Sell	35,353 -8,154	-19%	-$639K	0.67%	32
2020 Q2	$3.21M	Sell	43,507 -2,630	-6%	-$198K	0.47%	34
2020 Q1	$3.39M	Sell	46,137 -9,043	-16%	-$711K	0.57%	23
2019 Q4	$4.79M	Sell	55,180 -3,078	-5%	-$253K	0.52%	30
2019 Q3	$4.68M	Sell	58,258 -79	-0.1%	-$6.33K	0.66%	20
2019 Q2	$4.67M	Sell	58,337 -16,271	-22%	-$1.25M	0.47%	31
2019 Q1	$5.92M	Sell	74,608 -2,090	-3%	-$156K	0.53%	37
2018 Q4	$5.59M	Sell	76,698 -102,675	-57%	-$7.25M	0.56%	35
2018 Q3	$12.1M	Sell	179,373 -10,294	-5%	-$656K	0.66%	35
2018 Q2	$11M	Sell	189,667 -9,543	-5%	-$538K	0.65%	36
2018 Q1	$10.4M	Sell	199,210 -2,335	-1%	-$126K	0.67%	36
2017 Q4	$10.8M	Sell	201,545 -13,408	-6%	-$743K	0.69%	37
2017 Q3	$13.1M	Buy	214,953 +13,143	+7%	+$797K	0.82%	25
2017 Q2	$12.3M	Sell	201,810 -4,916	-2%	-$299K	0.86%	17
2017 Q1	$12.5M	Sell	206,726 -3,475	-2%	-$211K	0.86%	25
2016 Q4	$11.8M	Buy	210,201 +5,126	+2%	+$300K	0.83%	22
2016 Q3	$12.2M	Sell	205,075 -19,872	-9%	-$1.16M	0.89%	16
2016 Q2	$12.4M	Sell	224,947 -33,213	-13%	-$1.77M	0.93%	16
2016 Q1	$13M	Sell	258,160 -19,269	-7%	-$944K	0.92%	18
2015 Q4	$14M	Buy	277,429 +21,727	+8%	+$1.1M	0.94%	13
2015 Q3	$12.1M	Sell	255,702 -14,726	-5%	-$782K	0.85%	29
2015 Q2	$14.7M	Buy	270,428 +38,681	+17%	+$2.17M	0.82%	28
2015 Q1	$12.7M	Sell	231,747 -4,245	-2%	-$240K	0.78%	28
2014 Q4	$12.8M	Sell	235,992 -22,926	-9%	-$1.28M	0.74%	38
2014 Q3	$14.6M	Buy	258,918 +40,692	+19%	+$2.28M	0.77%	22
2014 Q2	$12M	Sell	218,226 -15,045	-6%	-$821K	0.58%	30
2014 Q1	$12.6M	Sell	233,271 -42,630	-15%	-$2.21M	0.53%	14
2013 Q4	$13.2M	Sell	275,901 -12,434	-4%	-$568K	0.5%	22
2013 Q3	$13.1M	Buy	+288,335	New	+$13.2M	0.44%	19

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cadence Capital Management's MRK Position: Q3 2020 in Review

Cadence Capital Management reduced its Merck (MRK) stake by 19% in Q3 2020, selling an estimated $639K and leaving 35,353 shares worth $2.8M. The position accounts for 0.67% of the portfolio, ranked #32.

Cadence Capital Management first reported a position in MRK in Q3 2013 and has held it in 29 quarters since. The position peaked at $14.7M in Q2 2015. 2,558 funds tracked by Wall St. Rank hold MRK as of Q3 2020.

Cadence Capital Management held 35,353 shares of Merck worth $2.8M as of Q3 2020.
Cadence Capital Management sold 8,154 Merck shares in Q3 2020, an estimated $639K.
Merck made up 0.67% of Cadence Capital Management's portfolio in Q3 2020, its #32 holding.
Cadence Capital Management first reported a position in Merck in Q3 2013 and has held it in 29 quarters since.
Cadence Capital Management's Merck position peaked at $14.7M in Q2 2015.
2,558 funds tracked by Wall St. Rank held Merck as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.